Stay updated with breaking news from Device Exemption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced an update on the COSIRA-II
Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of...
Recently, the U.S. Food and Drug Administration (FDA) released two proposed rules that aim to clarify inconsistencies between FDA’s human subject protection regulations and the Federal...
/PRNewswire/ -- Following our communication last week "MedAlliance to be acquired by Cordis", MedAlliance is pleased to make the following announcement:...
GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last week "MedAlliance to be acquired by Cordis", MedAlliance is pleased to make the following announcement: SELUTION